GSK to rely more on Asian R&D
GlaxoSmithKline (GSK) has indicated it will rely more heavily on Asian R&D in the future and has already been stepping up its involvement in India and Singapore.
Archives for October 24, 2006
Clinphone heads down under
As the Asia-Pacific continues to be a hotspot for clinical trials activity, e-clinical provider ClinPhone has opened its first office in the region in the hope of gaining a head start.
Continuous coating firm eyes Europe
O'Hara Technologies chose the recent CPhI in Paris to show off the world's only dedicated continuous coating machine for pharmaceutical tablets.
Fisher Scientific Q3 goes from strength to strength
Fresh from Thermo's $10.4bn (€8.3bn) acquisition of the scientific equipment and instrument specialists, Fisher Scientific posted strong third quarter results that showed a profit rise of 62 per cent coupled with an 11 per cent increase in revenue.
Charles River Labs awarded $111.6m NCI contract
Charles River Laboratories has been awarded a $111.6m (€89m), 10-year contract from the National Cancer Institute (NCI), doubling the size of the company's current contract with NCI.
Lilly injects $560m into US biotech plant expansion but will shut UK plant
Drug maker Eli Lilly has completed the first phase of a $560m (€446m) expansion of its biotech facility in Indianapolis, US, in order to match the growing number of biological drugs in its pipeline.
A world of outsourcing awaits - part III drug manufacturing
Although manufacturing is the most established of the pharma outsourcing segments, many service areas are still rapidly evolving. OutsourcingPharma.com gives a brief run down of the current state of play.
European cardiovascular drugs market set to rocket to new heights
According to a new study the European cardiovascular drugs market is expected to reach $36.3bn (€28.9bn) in 2012, buoyed on by new drug areas, classes and combination products.
Curalogic appoints SAFC to provide protein research services
Curalogic, a Danish biotechnology company, has appointed SAFC's Pharma business segment to provide protein isolation, extraction and purification services as part of its product development to treat Allergic Rhinitis.
A world of outsourcing awaits - Part II clinical research
Pharma companies that aren't maximising their outsourcing potential in clinical research may be wasting a world of opportunity. OutsourcingPharma.com gives a brief run down of exactly what kinds of services and providers are out there just waiting to...